01/23/2025
3:15 PM | Domzalski David (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
3:15 PM | Harsch Mutya (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
3:15 PM | Stuart Iain (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
3:15 PM | VYNE Therapeutics (Issuer)
Zeronda Tyler (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
5:06 PM | LEPORE PATRICK G (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
6:50 AM | VYNE Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2025
4:45 PM | Domzalski David (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
4:45 PM | Harsch Mutya (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
4:45 PM | Stuart Iain (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
4:45 PM | VYNE Therapeutics (Issuer)
Zeronda Tyler (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
6:42 AM | VYNE Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for VYNE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for VYNE Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
12/19/2024
3:27 PM | VYNE Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/13/2024
3:15 PM | Bruno Anthony D (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
3:15 PM | Sandoval Elisabeth (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
3:15 PM | BARBARI SHARON (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
3:15 PM | Basta Steven L (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
3:15 PM | LEPORE PATRICK G (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
3:15 PM | Borowski Christine (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
7:03 AM | VYNE Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2024
7:01 AM | VYNE Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
7:04 AM | VYNE Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
3:30 PM | Domzalski David (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
7:00 AM | VYNE Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2024
4:02 PM | Domzalski David (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
4:04 PM | Harsch Mutya (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
11:15 PM | VYNE Therapeutics (Filer)
| Form EFFECT | |
03/01/2024
4:15 PM | VYNE Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/01/2024
4:16 PM | VYNE Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/29/2024
7:12 AM | VYNE Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free VYNE Stock Alerts